BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7007882)

  • 1. Leukemia relapse in donor cells after allogeneic bone-marrow transplantation.
    Newburger PE; Latt SA; Pesando JM; Gustashaw K; Powers M; Chaganti RS; O'Reilly RJ
    N Engl J Med; 1981 Mar; 304(12):712-4. PubMed ID: 7007882
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic marrow grafting for acute lymphoblastic leukemia: leukemic relapse.
    Storb R; Bryant JI; Buckner CD; Clift RA; Fefer A; Fialkow PJ; Johnson FL; Neiman P; Thomas ED
    Transplant Proc; 1973 Mar; 5(1):923-6. PubMed ID: 4572153
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukemia relapse in host cells 5 years after bone marrow transplantation for acute non-lymphocytic leukemia in first complete remission.
    van't Veer-Korthof ET; van Weel-Sipman MH; Hählen K; Heurkens AH; Vossen JM
    Bone Marrow Transplant; 1988 Nov; 3(6):647-51. PubMed ID: 3063332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is leukemic transformation of donor cells possible?].
    Vinogradova OA; Savchenko VG; Domracheva EV; Parovichnikova EN; Diachenko LV; Alimova GA; Mendeleeva LP; Liubimova LS; Sokolov AN; Zhelnova EI; Pokrovskaia OS
    Ter Arkh; 2004; 76(7):28-34. PubMed ID: 15379124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic conversion of T-lineage lymphoblasts in the lymph node to myeloblasts in the bone marrow during relapse after allogeneic bone marrow transplantation.
    Matsumoto Y; Kawano C; Kametaka M; Otsuki T; Hatake K; Muroi K; Ozawa K
    Int J Hematol; 2000 Aug; 72(2):253-4. PubMed ID: 11039678
    [No Abstract]   [Full Text] [Related]  

  • 7. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
    Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
    Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chromosome studies on the bone marrow from children with acute lymphoid leukemia and preleukemia].
    Károlyi G; Kosztolányi G; Kajtár P; Molnár S
    Orv Hetil; 1981 Aug; 122(34):2087-91. PubMed ID: 6946387
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemic relapse in the central nervous system after allogeneic stem cell transplantation with complete remission in the bone marrow and donor-type chimerism: report of two cases.
    Ohashi H; Kato C; Fukami S; Saito H; Hamaguchi M
    Am J Hematol; 2005 Jun; 79(2):142-6. PubMed ID: 15929112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell acute lymphoblastic leukemia (ALL) in donor cells following bone marrow transplantation for T cell ALL.
    Feig SA; Dreazen O; Simon M; Wiley F; Schreck R; Gale RP
    Bone Marrow Transplant; 1988 Jul; 3(4):331-7. PubMed ID: 2844347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    van Rhee F; Szydlo RM; Hermans J; Devergie A; Frassoni F; Arcese W; de Witte T; Kolb HJ; Niederwiser D; Jacobsen N; Gahrton G; Bandini G; Carreras E; Bacigalupo A; Michallet M; Ruutu T; Reiffers J; Goldman JM; Apperley J; Gratwohl A
    Bone Marrow Transplant; 1997 Oct; 20(7):553-60. PubMed ID: 9337056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course.
    Lee KH; Lee JH; Choi SJ; Lee JH; Kim S; Seol M; Lee YS; Kim WK; Seo EJ; Park CJ; Chi HS; Lee JS
    Bone Marrow Transplant; 2003 Oct; 32(8):835-42. PubMed ID: 14520431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia.
    Blume KG; Beutler E; Bross KJ; Chillar RK; Ellington OB; Fahey JL; Farbstein MJ; Forman SJ; Schmidt GM; Scott EP; Spruce WE; Turner MA; Wolf JL
    N Engl J Med; 1980 May; 302(19):1041-6. PubMed ID: 6245359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thymus in patients with allogeneic bone marrow transplants.
    Beschorner WE; Hutchins GM; Elfenbein GJ; Santos GW
    Am J Pathol; 1978 Jul; 92(1):173-86. PubMed ID: 356622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairs.
    Thomas ED; Bryant JI; Buckner CD; Clift RA; Fefer A; Fialkow PJ; Funk DD; Neiman PE; Rudolph RH; Slichter SJ; Storb R
    Trans Assoc Am Physicians; 1971; 84():248-61. PubMed ID: 4151544
    [No Abstract]   [Full Text] [Related]  

  • 18. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change in cell line in relapses of acute lymphoid leukemia: frequency, morphologic, phenotypic and cytogenetic characteristics and clinical course].
    del Porto E; Díaz Mediavilla J; Ferro MT; Jordá J; Alvarez A; Villegas A; Espinós D
    Med Clin (Barc); 1988 Jan; 90(3):106-9. PubMed ID: 3162547
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.
    Kersey JH; Weisdorf D; Nesbit ME; LeBien TW; Woods WG; McGlave PB; Kim T; Vallera DA; Goldman AI; Bostrom B
    N Engl J Med; 1987 Aug; 317(8):461-7. PubMed ID: 3302708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.